Predisposition Testing for Inherited Breast Cancer

ONCOLOGY

Volumn 12, Issue 8, 1998, Pages 1227-1241

  Cummings, Shelly ^a   Olopade, Olufunmilayo ^a  

^a The University of Chicago Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BREAST TUMOR; CASE REPORT; ESTROGEN THERAPY; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; METHODOLOGY; MIDDLE AGED; MUTATION; PEDIGREE; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; MUTATION; PEDIGREE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0032129510     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. American Cancer Society: Cancer Facts and Figures - 1997. Atlanta, American Cancer Society, 1997
2. Zopf PE: Mortality Patterns & Trends in the United States, p 125. Westport, Greenwood Press, 1992.
3. Amos CI. Identifying gene-environment interactions in cancer etiology Cancer Bull 46:214, 1994.
4. Easton D, Ford D, Peto J. Inherited susceptibility to breast cancer, in Fentiman IS, Taylor-Papadimitriou (eds): Cancer Surveys: Breast Cancer, vol 18, p 95. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press, 1993.
5. Claus EB, Risch NJ, Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232, 1991.
6. Gail MH, Benichou J. Assessing the risk of breast cancer in individuals, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer Prevention, pp 1-15. Philadelphia, JB Lippincott, 1992.
7. Easton DF, Bishop DT, Ford D, et al: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678, 1993.
8. Ford D, Easton DS, Bishop DT, et al: Risks of cancer in BRCA1-mutation carriers Lancet 343:692, 1994
9. Futreal PA, Liu Q, Shattuck-Eidens D, et al: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122, 1994.
10. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1985.
11. Wooster R, Neuhausen SL, Mangion J, et al: Localization of a breast cancer susceptibility gene. BRCA2, to chromosome 13q12-13. Science 285:2088-2090, 1994.
12. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene. BRCA2. Nature 378:789-792, 1995.
13. Tavtigian SV, Simard J, Rommens J, et al: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333-337, 1996.
14. Berman DB, et al A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Res 56:3409-3414, 1996.
15. Tonin P, Narod S, Ghadirian P, et al. A large multisite cancer family is linked to BRCA2. J Med Genet 32:982-984, 1995.
16. Grade K, Jandrig B, Scherneck S: BRCA1 mutation update and analysis. J Cancer Res Clin Oncol 122:702-706, 1996.
17. The Breast Cancer Information Core (BIC) database Web site, www.nchgr.nih gov/intramural_research/lab_transfer/bio/.
18. Struewing JP, Abeliovich D, Peretz T, et al: The carrier frequency of the BRCA1 185delAG mutation is approximately 1% in Ashkenazi Jewish Individuals. Nat Genet 11: 198-200, 1995.
19. Neuhausen SL, Mazoyer S, Friedman L, et al: Haplotype and phenotype analysis of 6 recurrent BRCA1 mutations in 61 families: Results of an international study. Am J Hum Genet 58:271-280, 1996
20. Simard J, Tonin P, Durocher F, et al: Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392-8, 1994
21. Thorlacius S, Olafsdottir S. Tryggvadottirr L, et al: Study of a single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117-21, 1996.
22. Gao Q, Neuhausen S, Cummings, et al: Recurrent germ-line BRCA1 mutations in extended African-American families with early onset breast cancer. Am J Hum Genet 60:1233-6, 1997.
23. Neuhausen S, Gilewski T, Offit K, et al: Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13:126-128, 1996.
24. Roa BB, Boyd AA, Volcik K, et al: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187, 1996.
25. Peelan T, van Viet M, Petrij-Bosch A, et al: A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian families. Am J Hum Genet 60:1041-9, 1997.
26. Liaw D, Eng C, Parsons R, et al: Germline mutations of the PTEN gene in Cowden disease, and inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67, 1997.
27. Savitsky K, Bar-Shira A, Collins F, et al: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753, 1995.
28. Myriad Genetic Laboratories: BRCA analysis technical specifications. Updated November 19, 1996.
29. Yershov G, Barsky V, Belgovski A, et al: DNA analysis and diagnostics on oligonucleotide microchips. Proc Natl Acad Sci USA 93:4913-4918, 1996.
30. Hacia JG, Brody L, Collins FS, et al: Delection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-color fluorescence analysis. Nat Genet 14:441-447, 1996.
31. Easton DF, Ford D, Bishop DT, et al : Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271, 1995.
32. Frank TS, Manley S, Thomas A, et al: BRCA1 and BRCA2 Sequence analysis of 335 high-risk women. Proceedings of the 47th Annual Meeting of the American Society of Human Genetics, 1997.
33. Couch F, Weber B, DeShano M, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415, 1997.
34. NIH: NCHGR, NCI, NINR & NIMH take on issues related to genetic testing for cancer risk. NIH News, pp 1-4, October 3, 1994.
35. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14(5): 1730-1736, 1996.
36. Rubin SC, Benjamin I, Behbakht K, et al: Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Eng J Med 335:1413-1416, 1996.
37. King MC, Rowell S, Love SM: Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 269:1975, 1993.
38. Genetic risk and screening techniques for epithelial ovarian cancer. ACOG Committee Opinion: Committee on Gynecologic Practice, number 117 - December 1992. Int J Gynaecol Obstet 41(3):321-323, 1993.
39. NIH Consensus Development Panel on Ovarian Cancer: Ovarian cancer. JAMA 273(6):491-497, 1995.
40. Hartmann L, Jenkins R, Schaid D, et al: Prophylactic mastectomy: Preliminary retrospective cohort analysis. Proc Am Assoc Can Res 38:1123, 1997.
41. Biesecker BB, Boehnke M, Calzone K, et al: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269:1970, 1993.
42. Humphrey LJ: Subcutaneous mastectomy is not a prophylaxis against carcinoma of the breast: Opinion or knowledge? Am J Surg 145:311, 1983.
43. Piver MS, Baker TR: Etiology, biology and epidemiology of ovarian cancer. Semin Surg Oncol 10:242, 1994.
44. Ursin G, Henderson BE, Halle RW, et al: Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res 57(17):3678-3681, 1997.